These trials results form the basis of the safety and efficacy data
Some of these strategies address managing utilization, both for drugs specifically approved for weight loss, as well as the off-label use of those approved for treatment of diabetes
Until Phase II and III results emerge with proper endpoints (mucosal healing rates, histologic remission, patient-reported outcomes), the evidence base will remain preclinical
To our knowledge, there is no similar case in the literature with this pattern of dissemination
Unlike palm reading, this is about determining your personality traits, your energy, and your general outlook in life
Yes, the SURMOUNT-1 clinical trial specifically focused on adults with obesity or overweight who did not have diabetes